Clinical Trial: A Randomized, Controlled Clinical Study on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Combined With Standard Immunosuppressants in the Treatment of Children With Severe Aplastic Anemia

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903649) titled 'A Randomized, Controlled Clinical Study on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Combined With Standard Immunosuppressants in the Treatment of Children With Severe Aplastic Anemia' on Oct. 23.

Brief Summary: Study on the efficacy and safety of umbilical cord mesenchymal stem cells combined with standard immunosuppressive agents in the treatment of children with acquired severe aplastic anemia

Study Start Date: Feb. 25, 2021

Study Type: INTERVENTIONAL

Condition: Sever Aplastic Aneia Children Umbilical Cord Mesenchymal Stem Cells

Intervention: OTHER: Umbilical Cord Mesenchymal Stem Cells with ATG/ALG ...